946761319	946761319	CD	B-NP	O
|	|	NN	I-NP	O
ACH	ACH	NN	I-NP	O
|	|	NN	I-NP	O
01388286	01388286	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6553061	6553061	CD	B-NP	O
|	|	CC	I-NP	O
6/9/2004	6/9/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/9/2004	6/9/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
YONG	YONG	NNP	B-NP	O
KINGSTON	KINGSTON	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
TUHAMC	TUHAMC	NN	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Pegram	Pegram	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Flora	Flora	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
has	have	VBZ	B-VP	O
exertional	exertional	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
experiencing	experience	VBG	I-VP	O
increasing	increase	VBG	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
of	of	IN	B-PP	O
late	late	JJ	B-NP	O
and	and	CC	I-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
CT	CT	NN	B-NP	O
surgery	surgery	NN	I-NP	O
for	for	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
to	to	TO	B-VP	O
correct	correct	VB	I-VP	O
her	her	PRP$	B-NP	O
CAD	CAD	NN	I-NP	O
and	and	CC	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
office	office	NN	I-NP	O
visit	visit	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rudicil	Rudicil	NNP	I-NP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
terrible	terrible	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Nacke	Nacke	NNP	I-NP	O
referred	refer	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Clare	Clare	NNP	I-NP	O
Taho	Taho	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ED	ED	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
91/54	91/54	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
16	16	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
2-mm	2-mm	JJ	B-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	O
V4	V4	NN	I-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
,	,	,	O	O
Mucomyst	Mucomyst	NNP	B-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
pain-free	pain-free	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
lab	lab	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	B-DNA
#	#	#	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
placed	place	VBN	I-NP	I-DNA
6/21/04	6/21/04	CD	I-NP	I-DNA
was	be	VBD	B-VP	O
no	no	RB	B-NP	O
longer	long	JJR	I-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
told	tell	VBD	B-VP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
was	be	VBD	B-VP	O
possible	possible	JJ	B-ADJP	O
after	after	IN	B-SBAR	O
her	her	PRP$	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	B-DNA
#	#	#	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
involved	involve	VBD	B-VP	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
free	free	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
FEM-POP	FEM-POP	NNP	B-NP	O
and	and	CC	O	O
fem-fem	fem-fem	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
cadaveric	cadaveric	JJ	B-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
,	,	,	O	O
currently	currently	RB	B-VP	O
immunosuppressed	immunosuppresse	VBN	I-VP	O
.	.	.	O	O

IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
TIA	TIA	NN	B-NP	B-protein
,	,	,	O	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
CMV	CMV	NN	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bladder	bladder	NN	B-NP	B-protein
CA	CA	NN	I-NP	I-protein
,	,	,	O	O
recent	recent	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
not	not	RB	O	O
yet	yet	RB	B-ADVP	O
worked	work	VBN	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
azathioprine	azathioprine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
lispro	lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Compazine	Compazine	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Ameling	Ameling	NNP	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
suite	suite	NN	I-NP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
circumflex	circumflex	NN	I-NP	O
was	be	VBD	B-VP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diagonal	diagonal	JJ	I-NP	O
#	#	#	I-NP	O
1	1	CD	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
now	now	RB	B-ADVP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
stenosed	stenose	VBN	B-VP	O
and	and	CC	O	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
native	native	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
graft	graft	NN	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
PTCA	PTCA	NN	B-NP	O
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
occluded	occlude	VBN	I-NP	O
diagonal	diagonal	JJ	I-NP	O
#	#	#	I-NP	O
1	1	CD	I-NP	O
stent	stent	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
,	,	,	O	O
bradycardic	bradycardic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
cardiogenic	cardiogenic	JJ	B-NP	O
shock	shock	NN	I-NP	O
requiring	require	VBG	B-VP	O
CPR	CPR	NN	B-NP	B-protein
and	and	CC	I-NP	O
intubation	intubation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
IBP	IBP	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-ADVP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
effusion	effusion	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
apparently	apparently	RB	I-NP	O
low	low	JJ	I-NP	O
EF	EF	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
transient	transient	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
flow	flow	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
septal	septal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
likely	likely	RB	B-ADJP	O
compounded	compound	VBD	B-VP	O
her	her	PRP	B-NP	O
acute	acute	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intraaortic	intraaortic	JJ	I-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
absent	absent	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
cool	cool	JJ	B-ADJP	O
to	to	TO	B-VP	O
touch	touch	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
intubated	intubated	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sedated	sedated	JJ	I-ADJP	O
,	,	,	O	O
unresponsive	unresponsive	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
had	have	VBD	B-VP	O
coarse	coarse	NN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
anterolaterally	anterolaterally	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
without	without	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
or	or	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gallop	gallop	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
harsh	harsh	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
somewhat	somewhat	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
belly	belly	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
with	with	IN	B-PP	O
absent	absent	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
mottled	mottle	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
notably	notably	RB	B-ADJP	O
cooler	cool	JJR	I-ADJP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
over	over	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.92	0.92	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
191	191	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
later	later	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
dialysis	dialysis	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
inferoseptal	inferoseptal	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
taken	take	VBN	I-VP	O
out	out	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
dopamine	dopamine	NN	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
and	and	CC	I-VP	O
extubated	extubate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
on	on	IN	B-PP	O
9/1/04	9/1/04	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
experienced	experience	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
unstable	unstable	JJ	B-NP	B-protein
VT	VT	NN	I-NP	I-protein
arrest	arrest	NN	I-NP	I-protein
requiring	require	VBG	B-VP	I-protein
shock	shock	NN	B-NP	I-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

no	no	DT	B-NP	O
further	further	JJ	I-NP	O
defibrillation	defibrillation	NN	I-NP	O
was	be	VBD	B-VP	O
needed	need	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
stabilized	stabilize	VBD	B-VP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
V-TACH	V-TACH	NN	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	I-NP	O
shocking	shocking	NN	I-NP	O
and	and	CC	O	O
per	per	IN	B-PP	O
Electrophysiology	Electrophysiology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

after	after	IN	B-PP	O
being	be	VBG	B-VP	O
titrated	titrate	VBN	I-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

BY	BY	NNP	B-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Quigg	Quigg	NNP	I-NP	O
has	have	VBZ	B-VP	O
terrible	terrible	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
offered	offer	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
Dr.	Dr.	NNP	B-NP	O
Kohler	Kohler	NNP	I-NP	O
's	's	POS	B-NP	O
Surgical	Surgical	JJ	I-NP	O
team	team	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
EP	EP	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
undergo	undergo	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
catheterizations	catheterization	NNS	I-NP	O
or	or	CC	I-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
briefly	briefly	RB	B-ADVP	O
on	on	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
or	or	CC	O	O
an	an	DT	B-NP	O
ARB	ARB	NN	I-NP	B-protein
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
remains	remain	VBZ	B-VP	O
poor	poor	JJ	B-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
plans	plan	NNS	I-NP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
or	or	CC	I-NP	O
ARB	ARB	NN	I-NP	B-protein
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Livernoche	Livernoche	NNP	I-NP	O
has	have	VBZ	B-VP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
undergoing	undergo	VBG	I-VP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
and	and	CC	O	O
regularly	regularly	RB	B-VP	O
is	be	VBZ	I-VP	O
getting	get	VBG	I-VP	O
several	several	JJ	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
session	session	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
tolerates	tolerate	VBZ	B-VP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Mcelhiney	Mcelhiney	NNP	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
and	and	CC	I-NP	O
unstable	unstable	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
requiring	require	VBG	B-VP	O
shocking	shocking	NN	B-NP	O
.	.	.	O	O

Electrophysiology	Electrophysiology	NN	B-NP	O
evaluated	evaluate	VBD	B-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
deferred	defer	VBN	I-VP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
ever	ever	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
AICD	AICD	NNP	I-NP	O
placed	place	VBD	B-VP	O
,	,	,	O	O
certainly	certainly	RB	B-ADVP	O
not	not	RB	O	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
800	800	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
split	split	VBN	B-VP	O
into	into	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-LST	O
and	and	CC	O	O
after	after	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
take	take	VB	I-VP	O
place	place	NN	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
She	She	NNP	I-NP	O
initially	initially	RB	B-ADVP	O
tolerated	tolerate	VBD	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
very	very	RB	B-ADJP	O
poorly	poorly	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
gradually	gradually	RB	B-ADVP	O
.	.	.	O	O

c.	c.	LS	B-NP	O
Peripheral	Peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Fassett	Fassett	NNP	I-NP	O
has	have	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
compartment	compartment	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
calf	calf	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
ischemia	ischemia	NN	B-NP	O
upon	upon	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
intraaortic	intraaortic	JJ	B-NP	O
balloon	balloon	NN	I-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
having	have	VBG	I-VP	O
the	the	DT	B-NP	O
circumferences	circumference	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cath	cath	NN	I-NP	O
measured	measure	VBN	B-VP	O
once	once	RB	B-ADVP	O
or	or	CC	I-ADVP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
increasing	increase	VBG	I-VP	O
,	,	,	O	O
have	have	VBP	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
been	be	VBN	B-VP	O
decreasing	decrease	VBG	I-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
surrogate	surrogate	NN	I-NP	O
for	for	IN	B-PP	O
compartment	compartment	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
decreasing	decrease	VBG	I-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
currently	currently	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
75	75	CD	B-NP	O
down	down	IN	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
cath	cath	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tender	tender	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
gradually	gradually	RB	I-VP	O
returned	return	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pulses	pulse	NNS	I-NP	O
remained	remain	VBD	B-VP	O
poor	poor	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
Dopplers	Doppler	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP	B-NP	O
arterial	arterial	JJ	I-NP	O
venous	venous	JJ	I-NP	O
flow	flow	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
clot	clot	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
venous	venous	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
comment	comment	NN	I-NP	O
made	make	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
FEM-FEM	FEM-FEM	JJ	I-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
note	note	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
circumferences	circumference	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
calf	calf	NN	I-NP	O
followed	follow	VBD	B-VP	O
closely	closely	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
place	place	NN	I-NP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
marked	mark	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Barrete	Barrete	NNP	I-NP	O
has	have	VBZ	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.7	2.7	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
up	up	RB	B-ADVP	O
and	and	CC	I-ADVP	O
down	down	RB	I-ADVP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
relatively	relatively	RB	B-ADJP	O
anuric	anuric	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
occasionally	occasionally	RB	B-VP	O
produces	produce	VBZ	I-VP	O
small	small	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
carefully	carefully	RB	B-ADVP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
continuing	continue	VBG	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	I-NP	O
azathioprine	azathioprine	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
positive	positive	JJ	I-NP	O
UA	UA	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
extremely	extremely	RB	B-ADVP	O
concentrated	concentrate	VBD	B-VP	O
urine	urine	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
produce	produce	VB	I-VP	O
urine	urine	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
permanent	permanent	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
indefinitely	indefinitely	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
of	of	IN	B-PP	O
1000	1000	CD	B-NP	O
cc	cc	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
ARB	ARB	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Helmy	Helmy	NNP	I-NP	O
spiked	spike	VBD	B-VP	O
on	on	IN	B-PP	O
11/5/04	11/5/04	CD	B-NP	O
to	to	TO	B-PP	O
101.8	101.8	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
line	line	NN	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-DNA
triple-lumen	triple-lumen	JJ	I-NP	I-DNA
catheter	catheter	NN	I-NP	I-DNA
tip	tip	NN	I-NP	I-DNA
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
on	on	IN	B-PP	O
4/7/04	4/7/04	CD	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
dosed	dose	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
troughs	trough	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
drawn	draw	VBN	I-VP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
her	her	PRP$	B-NP	O
trough	trough	NN	I-NP	O
is	be	VBZ	B-VP	O
near	near	IN	B-PP	O
or	or	CC	I-PP	O
below	below	IN	I-PP	O
15	15	CD	B-NP	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
turned	turn	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
approximately	approximately	RB	B-NP	O
every	every	DT	I-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Kornn	Kornn	NNP	I-NP	O
's	's	POS	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
dropping	drop	VBG	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
100s	100s	CD	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
50s	50	NNS	I-NP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
is	be	VBZ	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
two	two	CD	B-NP	O
negative	negative	JJ	I-NP	O
HIT	HIT	NN	I-NP	O
antibodies	antibody	NNS	I-NP	O
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
stabilized	stabilize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
40s	40s	CD	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
50s	50	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
showing	show	VBG	I-VP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
communicated	communicate	VBN	I-VP	O
with	with	IN	B-PP	O
Electrophysiology	Electrophysiology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
amiodarone	amiodarone	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
causing	cause	VBG	I-VP	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
unless	unless	IN	B-SBAR	O
her	her	PRP$	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
worsens	worsen	VBZ	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
medications	medication	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-ADVP	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
timing	timing	NN	I-NP	O
was	be	VBD	B-VP	O
coincident	coincident	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Wenrich	Wenrich	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
on	on	IN	B-PP	O
10/14/04	10/14/04	CD	B-NP	O
,	,	,	O	O
600	600	CD	B-NP	O
cc	cc	NN	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transudative	transudative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
tap	tap	NN	I-NP	B-protein
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
slipping	slip	VBG	B-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
bed	bed	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
caught	catch	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
fall	fall	VB	I-VP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
completely	completely	RB	I-VP	O
drained	drain	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
hydropneumothorax	hydropneumothorax	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
hemothorax	hemothorax	NN	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
is	be	VBZ	B-VP	O
evident	evident	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-rays	x-ray	NNS	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
compromise	compromise	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
apparent	apparent	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
since	since	IN	B-SBAR	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
reaccumulate	reaccumulate	VB	I-VP	O
after	after	IN	B-PP	O
tapping	tap	VBG	B-NP	O
,	,	,	O	O
but	but	CC	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
becomes	become	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
symptomatic	symptomatic	JJ	I-ADJP	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
tapped	tap	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Delperdang	Delperdang	NNP	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
,	,	,	O	O
her	her	PRP$	B-NP	B-protein
transaminases	transaminase	NNS	I-NP	I-protein
bumped	bump	VBN	B-VP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
100s	100	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
total	total	JJ	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
also	also	RB	B-ADVP	O
bumped	bump	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
starting	start	VBG	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
have	have	VBP	B-VP	O
trended	trend	VBN	I-VP	O
down	down	RP	B-PRT	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
exactly	exactly	RB	B-ADVP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
LFTs	LFT	NNS	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Zocor	Zocor	NNP	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-SBAR	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
tolerate	tolerate	VBP	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Zocor	Zocor	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
hope	hope	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
class	class	NN	I-NP	O
effect	effect	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Zocor	Zocor	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
Ativan	Ativan	NNP	I-NP	O
and	and	CC	I-NP	O
Zofran	Zofran	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
Compazine	Compazine	NN	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Cubeta	Cubeta	NNP	I-NP	O
is	be	VBZ	B-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
family	family	NN	B-NP	O
does	do	VBZ	B-VP	O
desire	desire	VB	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
may	may	MD	B-VP	O
help	help	VB	I-VP	O
that	that	IN	B-SBAR	O
pressures	pressure	NNS	B-NP	O
in	in	IN	B-PP	O
shock	shock	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-5712077	7-5712077	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
KESSANS	KESSANS	NN	B-NP	O
,	,	,	O	O
WILLIAMS	WILLIAMS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DUBARD	DUBARD	NNP	B-NP	O
,	,	,	O	O
BROCK	BROCK	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6382117	6382117	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/28/04	6/28/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/28/04	6/28/04	CD	B-NP	O

